MSRRX
Price
$53.57
Change
+$0.03 (+0.06%)
Updated
Dec 26 closing price
Net Assets
8.12B
VFFSX
Price
$339.11
Change
-$0.07 (-0.02%)
Updated
Dec 26 closing price
Net Assets
1.48T
Interact to see
Advertisement

MSRRX vs VFFSX

Header iconMSRRX vs VFFSX Comparison
Open Charts MSRRX vs VFFSXBanner chart's image
MFS Research R2
Price$53.57
Change+$0.03 (+0.06%)
VolumeN/A
Net Assets8.12B
Vanguard 500 Index Institutional Select
Price$339.11
Change-$0.07 (-0.02%)
VolumeN/A
Net Assets1.48T
MSRRX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
MSRRX vs. VFFSX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSRRX is a Hold and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.48T vs. MSRRX (8.12B). VFFSX pays higher dividends than MSRRX: VFFSX (1.13) vs MSRRX (0.19). MSRRX was incepted earlier than VFFSX: MSRRX (22 years) vs VFFSX (10 years). MSRRX (1.02) is less costly to investors than VFFSX (0.01). MSRRX is a more actively managed with annual turnover of: 20.00 vs. VFFSX (2.00). MSRRX has a lower initial minimum investment than VFFSX: MSRRX (0) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 14.85 vs. MSRRX (-4.54). VFFSX return over 5 years is better than : 87.63 vs. MSRRX (11.37).
MSRRXVFFSXMSRRX / VFFSX
Total Expense Ratio1.020.0110,200%
Annual Report Gross Expense Ratio1.020.0110,200%
Fund Existence22 years10 years-
Gain YTD-2.45817.916-14%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.12B1.48T1%
Annual Yield % from dividends0.191.1317%
Returns for 1 year-4.5414.85-31%
Returns for 3 years21.1880.7626%
Returns for 5 years11.3787.6313%
Returns for 10 years56.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHOE15.990.86
+5.68%
Phoenix Asia Holdings Limited
CAPR29.680.78
+2.70%
Capricor Therapeutics
HALO68.410.05
+0.07%
Halozyme Therapeutics
CHPGU10.21N/A
N/A
Championsgate Acquisition Corp
GROV1.17-0.03
-2.50%
Grove Collaborative Holdings